The 7 most recent market catalysts affecting $MEDS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 18, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Friday's After-Market Session
This filing, generated by an automated content engine, simply reports the after-market price changes for a selection of healthcare stocks. It does not provide the underlying reason…
Sep 17, 2026
Corporate Catalyst
Bearish
Impact 65
Nebius Group, DataMEDS AI, Boeing, Generac Holdings and Delixy Holdings: Why These 5 Stocks Are on Investors' Radars Today
The filing details several distinct corporate catalysts driving investor interest in these five stocks. Nebius Group (NBIS) is benefiting from a strategic partnership with Palantir…
Sep 16, 2026
Corporate Catalyst
Bullish
Impact 92
DataMEDS AI Stock Soars 65% Pre-market: Here's What You Need to Know
DataMEDS AI (MEDS) announced the completion of its acquisition of Helomics Corp., an AI-driven cancer diagnostics laboratory, from Axe Compute Inc. (AGPU) for $1.5 million. This is…
Aug 17, 2026
Corporate Catalyst
Bearish
Impact 95
DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY
DataMEDS AI reported a substantial increase in losses per share, from $(5.40) to $(7.13) year-over-year, alongside a dramatic 77.15% drop in sales from $7.791 million to $1.780 mil…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 65
DataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution
DataMeds AI and Datavault AI have expanded their existing definitive agreement, allowing DataMeds AI to license Datavault AI's PharmacyChain blockchain technology for a much wider …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.